Skip to content

The effect on the digital therapeutics of community residents with abnormal glucose metabolism and MAFLD

The effect on the digital therapeutics of community residents with abnormal glucose metabolism and MAFLD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071067
Enrollment
Unknown
Registered
2023-05-04
Start date
2023-05-04
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of glucose and lipid metabolism

Interventions

intervention group:Subjects assigned to the intervention group were asked to register and use this mini app after intensive care by community nurses, track the subjects' weight and blood sugar through
control group:Participants received standard care trained by a specialist diabetes nurse, which included advice on diet and physical activity

Sponsors

Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde District, Foshan City)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Meet the diagnostic criteria for type 2 diabetes or prediabetes as defined by the ADA in 2021 2) Meet the diagnostic criteria for MAFLD as defined by the international expert consensus statement, in addition the CAP =248 dB/m detected by FibroScan ultrasounddiagnosis 3)the subjects aged from 18 to 75 years old, and be able to read and write 4) subjects owned and used smartphone 5)the BMI is greater than 23.0 kg/m2 6)willing to sign the informed consent

Exclusion criteria

Exclusion criteria: 1) subjects who cannot take care of themselves 2) With serious diabetic complications, such as retinal detachment, disability, etc 3) Stage 4 renal failure and above 4) Have severe cardiopulmonary insufficiency 5) Pregnant 6) With mental illness, such as depression, schizophrenia 7) Untreated hypothyroidism, thalassemia or blood diseases

Design outcomes

Primary

MeasureTime frame
weight;hemoglobin;CAP;LSM;

Secondary

MeasureTime frame
blood lipid;Waist-hip ratio;blood pressure;

Countries

China

Contacts

Public ContactShen Jie

Shunde Hospital, Southern Medical University

sjiesy@smu.edu.cn+86 13808893818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026